Efficacy remained steady at high levels at 52 weeks, and serious adverse effects were rare, extension trial finds. Medscape Medical News
Month: September 2021
Dupilumab Effective for Up To 1 Year in Teens With AD: Study
Efficacy remained steady at high levels at 52 weeks, and serious adverse effects were rare, extension trial finds. Medscape Medical News
VIDEO: Kreissig Lecture explores potential of neuroprotection in nonarteritic CRAO
At the virtual Euretina congress, Ogugua Okonkwo, MD, FRCS, delivered the Kreissig Lecture, focusing on the potential of neuroprotection as a treatment strategy for nonarteritic central retinal artery occlusion.
Opus Genetics founded with focus on inherited retinal diseases
The Retinal Degeneration Fund announced the launch of Opus Genetics, which will aim to develop gene therapy treatments for orphan inherited retinal diseases, according to a press release.Opus Genetics is the first spin-out company launched by the found…
2021 Report on Global Cataract Drugs In Development – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cataract (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Cataract (Ophthalmology) pipeline landscape. Cataract is a clouding…
Eyeglasses for students linked to higher test scores, better academic performance
In what may be the largest clinical study ever conducted in the United States of the impact of glasses on classroom performance, Johns Hopkins researchers report that students who received eyeglasses through a school-based program scored higher on read…
Study investigates safety, efficacy of Luxturna in real-world clinical practice
Initial findings from the real-world PERCEIVE study of voretigene neparvovec in patients with RPE65 mutation-associated inherited retinal dystrophy show safety and efficacy in line with those observed in pivotal trials.“Despite limited availability of …
NCX 4251 fails to meet primary, secondary endpoints in phase 2b blepharitis trial
NCX 4251 did not meet the primary or secondary efficacy endpoints in a phase 2b clinical trial investigating the ophthalmic suspension in patients with acute exacerbations of blepharitis, according to a press release from Nicox.However, NCX 4251 (fluti…
Zeiss showcases innovations, applications
Zeiss has introduced several technological and software applications as part of the Zeiss Medical Ecosystem.The technologies include the Quatera 700, a cataract workflow solution for lens replacement, the Eyeguide patient software application for patie…
Horizon Therapeutics plc Announces Agenda for Virtual R&D Day for Investors and Analysts on Sept. 29, 2021
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced the agenda for its virtual R&D Day for investors and analysts on Sept. 29, 2021. During the event, Horizon’s R&D leadership, executives and key opinion leaders wil…
2021 Allergic Conjunctivitis Report on Drugs in Development – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Allergic Conjunctivitis (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Allergic Conjunctivitis (Ophthalmology) pipeline lan…
Handheld Photoacoustic Device for Lymph Node Assessment
Researchers at Pohang University of Science & Technology in South Korea have developed a handheld photoacoustic device that can locate sentinel lymph nodes near the armpit. The technology could help clinicians to locate the correct lymph node from which to take a biopsy when checking for breast cancer metastases. At present, this process involves using […]
Pancreatic Organoids Grown Inside Synthetic Gel
A team at MIT has developed a technique to grow organoids, both from healthy and cancerous pancreatic tissue, using a synthetic gel that predictably mimics the pancreatic extracellular environment. Compared with naturally derived materials, the synthetic gel is consistent from batch to batch, meaning that it leads to more reproducible and predictable results when growing […]
Long-term care, treatment advances and community define glaucoma specialty
Before choosing a glaucoma fellowship, consider the long-term nature of the subspecialty and the changing paradigms in management philosophy, according to a speaker at the virtual Real World Ophthalmology meeting.The first thing Nina Goyal, MD, said sh…
Squid Healthcare Announces FDA 510(k) Submission for EyeMask MD®
DALLAS–(BUSINESS WIRE)– #510k–Squid Healthcare Announces FDA 510(k) Submission for EyeMask MD® Intended for Periocular Wellness after Surgical and Non-Surgical Procedures
Treatment landscape for presbyopia evolving toward noninvasive options
Noninvasive or minimally invasive approaches may be the solution for presbyopia before the onset of age-related cataract and a way to address the increasing need to perform close-range tasks.“The treatments that are currently available have not met our…
Teprotumumab used in patient with compressive optic neuropathy
A 65-year-old woman presented to the New England Eye Center with 4 weeks of decreased vision and 6 months of progressive ocular irritation, redness and retro-orbital pain in both eyes.She noted an unusual prominence of her eyes but denied any double vi…
Stuck haptic poses challenge during IOL exchange
While it is rare, there are some patients who will benefit from an IOL exchange.The reasons may include a desire to change the IOL power or, in this case, to change the type of IOL. It is easier to perform the IOL exchange in the week or two after the …
Pros and cons of capitated insurance contracts
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.Mitchell C. Shultz, MD, and Eva Liang, MD, join us th…
Presbyopia-correcting drop options a win for eye care providers, patients
Presbyopia is a very common age-related process that negatively impacts visual performance and quality of life. Nearly 120 million people in the United States and 2 billion around the world are impacted by presbyopia, and with the aging population the …